List view / Grid view
23 November 2015 | By Victoria White
The findings come from three studies investigating the use of Keytruda (pembrolizumab) in combination with three other immunotherapies – epacadostat, Imlygic (talimogene laherparepvec), and ipilimumab – in patients with advanced melanoma...
23 November 2015 | By
Genvoya is the first TAF-based regimen to receive marketing authorisation in the EU...
23 November 2015 | By Victoria White
Perrigo will pay AstraZeneca $380 million upon completion of the transaction to acquire the rights to sell Entocort capsules...
23 November 2015 | By Victoria White
The combined company, to be named Pfizer plc, will be the biggest drug maker in the world by sales...
23 November 2015 | By Victoria White
The positive draft guidance follows the development of a managed access scheme by BioMarin and NHS England...
23 November 2015 | By Victoria White
Ninlaro (ixazomib) is the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma...
23 November 2015 | By Victoria White
The EC has approved secukinumab (Costenyx) for the treatment of people living with ankylosing spondylitis and psoriatic arthritis...
20 November 2015 | By Victoria White
Health experts are calling on lawmakers to close loopholes in the Orphan Drug Act that, they claim, give drug companies millions of dollars in unintended and misplaced subsidies and tax breaks...
20 November 2015 | By HORIBA Scientific
HORIBA Scientific, global leader in spectroscopic solutions, is pleased to announce that Francis Ndi, current Export Manager, has been promoted to Product Line Manager for the Optical Spectroscopy Division (OSD)...
20 November 2015 | By Victoria White
Baxalta expects to begin treating participants in the open-label, dose-finding study by early 2016...
20 November 2015 | By Victoria White
Orkambi (lumacaftor/ivacaftor), authorised for use in patients who have two copies of the F508del mutation, is the first medicine to treat the underlying cause of cystic fibrosis...
20 November 2015 | By Victoria White
Previously known as SB4, Benepali (etanercept) is a biosimilar candidate to the reference product Enbrel...
20 November 2015 | By Victoria White
The announcement makes Kyprolis (carfilzomib) the first irreversible proteasome inhibitor approved in the EU for use in combination treatment of patients with relapsed multiple myeloma.
19 November 2015 | By Victoria White
In the study, treatment with ALS-00876 resulted in a significant reduction of viral load and faster viral clearance versus placebo...
19 November 2015 | By Victoria White
The new Cancer Drugs Fund will become an instrument for the collection of important information on longer term benefits which may not be available at the time of licensing...
